摘要
目的:探讨CD44v6对胶质瘤细胞生长的影响及其相关机制。方法:细胞免疫荧光染色观察A172细胞中CD44v6表达情况及其表达部位。实时荧光定量PCR和Western blot检测A172细胞中CD44v6以及siRNA下调CD44v6表达的情况,MTT检测CD44v6对细胞活力的影响,AnnexinⅤ-FITC/PI染色检测CD44v6对细胞凋亡的影响,Western blot检测细胞中p-Akt水平。结果:A172细胞表达CD44v6,表达部位在细胞膜。siRNA下调CD44v6表达后,细胞生长显著减缓,细胞凋亡增加。CD44v6配体-骨桥蛋白促进A172细胞Akt的磷酸化,下调CD44v6表达后,骨桥蛋白的这种效应被显著抑制。进一步,骨桥蛋白促进A172细胞生长,下调CD44v6表达后,骨桥蛋白促进A172细胞生长的效应消失。结论:CD44v6增加A172细胞活力,抵抗细胞凋亡,其促进细胞内Akt的磷酸化是其中的一个机制。
Objective:To investigate the effect of CD44v6 on the growth of glioma cells and its mechanism. Methods:Cell inmmnofluorescence staining was used to detect the expression of CD44v6 and its expression site in A172 cells. Real-time fluorescence quantitative PCR and Western blot were used to detect the expression of CD44v6 in normal and siRNA-treated A172 cells. MTT was used to detect the effects of CD44v6 on A172 cell growth. Annexin V - FITC/PI staining was used to detect the effect of CD44v6 on cell apoptosis. Western blot was used to detect the expression level of p-Akt in A172 cells. Results : CD44v6 was expressed in cell membrane of A172 cells. There were significantly decreases in the cell growth and apoptosis increases compared in the normal group when CD44v6 was down - regulated by siRNA. Akt phosphorylation was induced by CD44v6 ligand osteopontin,while the above effect of osteopontin was significantly inhibited through down - regulating the expression of CIM4v6 protein by CD44v6 siRNA in A172 cells. Furthermore,osteopontin promoted the growth of A172 cells,while the above effect of osteopontin was also significantly inhibited through down - regulating the expression of CD44v6 protein by CD44v6 siRNA. Conclusion :CIN4~6 increased the cell viability and resisted apoptosis by promoting the phosphorylation of Akt in A172 cells.
作者
胡军
程妮
钟占强
冯华
周建军
Hu Jun;Cheng Ni;Zhong Zhanqiang;Feng Hua;Zhou Jianjun(Department of Neurology,Shaanxi People's Hospital,Shaanxi Xi'an 710068,China;Internal Medicine,the Fifth Hospital of Xi'an,Shaanxi Xi'an 710082,China;Department of Pain,The 323 Hospital of PLA,Shaanxi Xi'an 710054,China;Department of Neurosurgery,Southwest Hospital,Army Medical University,Chongqing 400038,China.)
出处
《现代肿瘤医学》
CAS
2018年第19期3021-3025,共5页
Journal of Modern Oncology
基金
陕西省科学技术研究自然基金(编号:2013JM4006)
兰州军区医药卫生科研计划项目(编号:CLZ13JB18)
第三二三医院2012年度培育课题(编号:2012323A01)